LUP Statistics

Record

Title

ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience.

Type

Journal Article

Publ. year

2004

Author/s

Jerkeman, Mats; Leppä, S; Kvaløy, S; Holte, H

Department/s

Breastcancer-genetics

In LUP since

2016-04-01

Total	This Year	This Month
878	19	1

Downloads per country

United States of America	319 (36%)
Germany	72 (8%)
China	48 (5%)
India	28 (3%)
United Kingdom of Great Britain and Northern Ireland	25 (3%)
South Korea	22 (3%)
Egypt	21 (2%)
Indonesia	20 (2%)
Sweden	20 (2%)
Russian Federation	15 (2%)
Turkiye	15 (2%)
Thailand	14 (2%)
Japan	14 (2%)
Canada	14 (2%)
France	13 (1%)
Romania	11 (1%)
Australia	10 (1%)
Brazil	10 (1%)
Philippines	8 (1%)
Hong Kong (China)	7 (1%)
Taiwan (China)	7 (1%)
Italy	7 (1%)
Czechia	7 (1%)
Mexico	7 (1%)
Malaysia	6 (1%)
Iran	6 (1%)
Poland	6 (1%)
Ireland	6 (1%)
Colombia	5 (1%)
Viet Nam	4 (0%)
Saudi Arabia	4 (0%)
Iraq	4 (0%)
Serbia	4 (0%)
Portugal	4 (0%)
Bulgaria	4 (0%)
Singapore	4 (0%)
Finland	4 (0%)
South Africa	3 (0%)
Bangladesh	3 (0%)
Unknown	3 (0%)
Ukraine	3 (0%)
Netherlands (Kingdom of the)	3 (0%)
Nepal	3 (0%)
Israel	3 (0%)
Estonia	3 (0%)
Peru	3 (0%)
Latvia	2 (0%)
Lithuania	2 (0%)
Uruguay	2 (0%)
Jordan	2 (0%)
Luxembourg	2 (0%)
Pakistan	2 (0%)
Spain	2 (0%)
Ethiopia	2 (0%)
Croatia	2 (0%)
Greece	2 (0%)
Chile	2 (0%)
Denmark	2 (0%)
Namibia	1 (0%)
Ecuador	1 (0%)
Norway	1 (0%)
Honduras	1 (0%)
European Union location	1 (0%)
Guatemala	1 (0%)
Mauritius	1 (0%)
Syrian Arab Republic	1 (0%)
Macao	1 (0%)
Morocco	1 (0%)
Martinique	1 (0%)
Argentina	1 (0%)
Bosnia and Herzegovina	1 (0%)
Lebanon	1 (0%)
Bolivia	1 (0%)
Macedonia	1 (0%)
Nigeria	1 (0%)
Iceland	1 (0%)
Switzerland	1 (0%)
Hungary	1 (0%)
Austria	1 (0%)
Palestinian Territory	1 (0%)
Jamaica	1 (0%)
Yemen	1 (0%)
Algeria	1 (0%)
Libya	1 (0%)
Barbados	1 (0%)
Kenya	1 (0%)
New Zealand	1 (0%)